Which lens after cataract surgery gives you the best sight at all distances?

NCT ID NCT07715071

Not yet recruiting Disease control Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This trial compares two types of artificial lens implants used during cataract surgery: enhanced monofocal lenses and extended depth-of-field lenses. The goal is to see which one provides better vision at far, intermediate, and near distances, and whether one causes fewer visual disturbances like glare or halos. The study includes adults aged 45 to 80 with bilateral cataracts who have functional visual demands.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: intraocular lens implant (enhanced monofocal or extended depth of field)
What this could lead to: If successful, this could help cataract patients choose a lens that offers clearer vision at multiple distances, reducing dependence on glasses.
What could go wrong: This is a small, early-stage trial with 90 participants, so results may not apply to everyone. Some patients may experience visual disturbances like glare or halos.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT

More trials for these conditions

Other studies related to the condition(s) this trial covers.